SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
Bristol Myers Squibb at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Bristol Myers Squibb brings 4 presentations to SITC 2026 in Phoenix. Its program centres on new drugs in development and on the company's approach to scientific opportunity and partnerships. The most concrete item is iza-bren, its first bispecific antibody-drug conjugate, alongside pumitamig, an antibody that blocks both PD-L1 and VEGF-A.
| Organization | SITC 2026 Attendance |
|---|---|
Bristol Myers Squibb Princeton, NJ | |
Global pharmaceutical company whose immuno-oncology medicines include the checkpoint inhibitors nivolumab and ipilimumab. | Talk Thu Nov 5 1:45pm–1:55pm Talk Thu Nov 5 6:20pm–6:40pm Session Thu Nov 5 6:45pm–7:20pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Find decision makers at Bristol Myers Squibb
Tell us what you sell and we’ll find the people at Bristol Myers Squibb most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction